MBIO - Mustang Bio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
103.38M
Enterprise Value 3
40.46M
Trailing P/E
N/A
Forward P/E 1
-2.45
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
-2,067.60
Price/Book (mrq)
1.49
Enterprise Value/Revenue 3
-809.18
Enterprise Value/EBITDA 6
-1.05

Trading Information

Stock Price History

Beta (3Y Monthly) 2.04
52-Week Change 3-32.08%
S&P500 52-Week Change 314.27%
52 Week High 310.2000
52 Week Low 32.1800
50-Day Moving Average 32.9619
200-Day Moving Average 33.4989

Share Statistics

Avg Vol (3 month) 3301.87k
Avg Vol (10 day) 3182.67k
Shares Outstanding 539.61M
Float 24.11M
% Held by Insiders 139.58%
% Held by Institutions 19.14%
Shares Short (Oct 31, 2019) 4508.89k
Short Ratio (Oct 31, 2019) 41.96
Short % of Float (Oct 31, 2019) 41.81%
Short % of Shares Outstanding (Oct 31, 2019) 41.26%
Shares Short (prior month Sep 30, 2019) 41.2M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)79,044.00%

Management Effectiveness

Return on Assets (ttm)-33.31%
Return on Equity (ttm)-63.88%

Income Statement

Revenue (ttm)-50k
Revenue Per Share (ttm)-0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -38.43M
Net Income Avi to Common (ttm)-39.3M
Diluted EPS (ttm)-1.3250
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)82.63M
Total Cash Per Share (mrq)2.07
Total Debt (mrq)14.97M
Total Debt/Equity (mrq)20.95
Current Ratio (mrq)13.10
Book Value Per Share (mrq)1.80

Cash Flow Statement

Operating Cash Flow (ttm)-25.58M
Levered Free Cash Flow (ttm)-21.37M